NewsRx

Search our medical news database

AIDS Therapies

Escape From Anti-HIV MAbs Costly For Virus

Published in Vaccine Weekly, September 8th, 1997

Combinations of different anti-HIV monoclonal antibodies may both protect against the virus and prevent the emergence of viable escape mutants.

The findings by a research team from Aaron Diamond AIDS Research Center (ADARC) and Scripps Research Institute are based on intensive studies of a single human MAb, IgG1b12.

"The results suggest that escape from IgG1b12 neutralization is due to a local rather than a global modification of the gp120 [HIV envelope protein] structure," ADARC researcher Hongmei Mo et al. observed. "Our findings have implications for the therapeutic and prophylactic applications of antibodies for HIV-1 infection."

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook